한국 임상 의사들의 호르몬 대체요법의 처방 시작 시기 및 사용기간에 대한 성향조사

Abstract

Objectives: To identify the trends and attitudes of Korean physicians toward recommending when HRT is started and how long it is continued for postmenopausal women. Methods: In a cross sectional study was invited letter to complete and return enclosed questionnaires to Korean menopausal society members(physicians). Results: Most physicians recommended postmenopausal women to start HRT for any indication during perimenopausal period or at least within 5 years after menopause. For relieving menopausal symptoms, 38.8％ of respondents recommended continuing HRT till subsiding the symptoms and 35.5％ recommended in 5 years after menopause. However, there lacked a consistency of sex and age among subjects. For preventing osteoporosis, 41.2％ of respondents recommended continuing HRT for lifelong, although sex and age lacked consistency. For preventing cardiovascular disease, 37.2％ of respondents recommended continuing HRT for lifelong and 25.6％ recommended continuing HRT till between 5 and 10 years after menopause, although sex lacked consistency. Conclusions: Most Members of Korean menopausal society recommended starting HRT for any indications at least within 5 years after menopause. However, there was a discordance among Korean physicians regarding how long should be recommended to continue according to indications. Thus consensus for the duration of HRT will be needed among physicians.